Chemical Structure (Dronabinol 01)
Dronabinol
Product Images NDC 42858-869
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dronabinol (NDC 42858-869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Dronabinol 02)
This appears to be a report of a study on the effect of Dronabinol, at a dose of 2.5mg twice a day, versus placebo on appetite change, as measured by mm VAS, for a duration of several weeks. The asterisk in the last line indicates a significant statistical difference with a p-value of less than 0.05.*
Principal Display Panel (2.5 mg Capsule Bottle Label)
Principal Display Panel (5 mg Capsule Bottle Label)
The text describes a medication named Dronabinol in the form of capsules with a National Drug Code (NDC) of £2565.868.6 80 Capaukes.*
Principal Display Panel (10 mg Capsule Bottle Label)
This is a medication with the National Drug Code (NDC) 25686000, packaged in 60 capsules. The medication is called Dronabinol, and it is a USP Capsule. No further information is available due to the poor scan quality.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
